• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Revvity (RVTY)

Equity
Sell: $100.50|Buy: $111.43|Change: 1.71 (-1.57%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

Address

940 Winter Street
Waltham
MA
USA
02451

Telephone

+1 781 663-6900

Website

https://www.revvity.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Revvity Inc Fourth Quarter Earnings Conference Call for 20262027-02-02T08:00:00
Revvity Inc Fourth Quarter Earnings Results for 20262027-02-02T00:00:00
Revvity Inc Third Quarter Earnings Conference Call for 20262026-10-27T08:00:00
Revvity Inc Third Quarter Earnings Results for 20262026-10-27T00:00:00
Revvity Inc Second Quarter Earnings Conference Call for 20262026-07-28T08:00:00
Revvity Inc Second Quarter Earnings Results for 20262026-07-28T00:00:00
Revvity Inc First Quarter Earnings Conference Call for 20262026-04-28T08:00:00
Revvity Inc First Quarter Earnings Results for 20262026-04-28T00:00:00
Revvity Inc Annual General Meeting for 20262026-04-22T08:00:00
Revvity Inc Annual Report for 20252026-02-25T00:00:00
Revvity Inc Fourth Quarter Earnings Conference Call for 20252026-02-02T08:00:00
Revvity Inc Fourth Quarter Earnings Results for 20252026-02-02T00:00:00

Previous key dates

NameKey Date
Revvity Inc Annual Report for 20252026-02-25T00:00:00
Revvity Inc Fourth Quarter Earnings Conference Call for 20252026-02-02T08:00:00
Revvity Inc Fourth Quarter Earnings Results for 20252026-02-02T00:00:00
J.P. Morgan Healthcare Conference2026-01-13T09:45:00
Citi's 2025 Global Healthcare Conference2025-12-02T09:00:00
Jefferies 2025 London Healthcare Conference2025-11-18T14:00:00
UBS Global Healthcare Conference 20252025-11-10T08:00:00
Revvity Inc Third Quarter Earnings Conference Call for 20252025-10-27T08:00:00
Revvity Inc Third Quarter Earnings Result for 20252025-10-27T00:00:00
2025 Baird Global Healthcare Conference2025-09-09T14:35:00
2025 Wells Fargo Healthcare Conference2025-09-03T08:00:00
Revvity Inc Second Quarter Earnings Conference Call for 20252025-07-28T08:00:00
Revvity Inc Second Quarter Earnings Results for 20252025-07-28T00:00:00
Goldman Sachs 46th Annual Global Healthcare Conference2025-06-10T08:00:00
Bank of America Global Healthcare Conference 20252025-05-13T09:20:00
Revvity Inc First Quarter Earnings Conference Call for 20252025-04-28T08:00:00
Revvity Inc First Quarter Earnings Result for 20252025-04-28T00:00:00
Revvity Inc Annual General Meeting for 20252025-04-22T08:00:00
Revvity Inc Annual Report for 20242025-02-25T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.